INHIBITION OF OCULAR INFLAMMATION BY CHALCONE DERIVATIVES AND PREDNISOLONE

被引：11

作者：

CHIOU, GCY

YAO, QS

VARMA, RS

机构：

[1] Institute of Ocular Pharmacology, Department of Medical Pharmacology and Toxicology, Texas A&M University College of Medicine, College Station, Texas

[2] Center for Biotechnology, Baylor College of Medicine, The Woodlands, Texas

来源：

JOURNAL OF OCULAR PHARMACOLOGY | 1992年 / 8卷 / 03期

关键词：

D O I：

10.1089/jop.1992.8.213

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Posterior uveitis was induced by injection of 10 mug endotoxin intravitreally into rat eyes and anterior ocular inflammation was induced by injection of 0.75 mg of lens protein intracamerally into rabbit eyes. Four chalcone derivatives, RVC-556 (2'-hydroxychalcone), RVC-574 (2'-hydroxychalcone hydrazone), RVC-574P (2'-hydroxychalcone phenyl hydrazone) and RVC-588 (4,4'-dihydroxy chalcone) were studied along with prednisolone at a dose of 10 mg/kg i.p. t.i.d. for their anti-inflammatory actions. RVC-574 was more active than prednisolone in inhibiting posterior uveitis by 65% and 43%, respectively. RVC-556, RVC-574P, and RVC-588 did not affect the posterior uveitis in rats. On the other hand, anterior ocular inflammation was inhibited by 1% eyedrops of RVC-556, RVC-574P and RVC-588 but not by RVC-574. RVC-556 was more active than; RVC-574P was less active than; and RVC-588 was about equiactive as prednisolone in inhibiting anterior ocular inflammation by 77%, 47%, 69% and 64%, respectively.

引用

页码：213 / 223

页数：11

共 13 条

[1]

Bhattacherjee Z., Hammon B., Salmon J., Eckins K., Effects of lipoxygenase products on leukocyte accumuuation in the rabbit eye, Leukotrienes and Other Lipoxygenase Products, pp. 325-330, (1982)

[2]

Brown F.J., Bernstein P.R., Cronk L.A., Dosset D.L., Hebbel K.C., Maduskuie T.P., Shapiro H.S., Vacek E.P., Yee Y.K., Willard A.K., Krell R.D., Snyder D.W., Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes, J. Med. Chem, 32, pp. 807-826, (1989)

[3]

Chang M.S., Chiou G.C.Y., Prevention of lens protein-induced ocular inflammation with cyclooxygenase and lipoxygenase inhibitors, J. Ocular Pharmacol, 5, pp. 353-360, (1989)

[4]

Chiou G.C.Y., Chang M.S., Ocular infaammation induced by lens protein and its prevention with new agents, New Trends in Lipid Mediators Research, pp. 94-109, (1990)

[5]

Chiou L.Y., Chiou G.C.Y., Ocular anti-inflammatory action of a lipoxygenase inhibitor in the rabbit, J. Ocular Pharmacol, 1, pp. 383-389, (1985)

[6]

Dhar D.N., The Chemistry of Chalcones and Related Compounds, (1981)

[7]

Ellis P.P., Ocular Therapeutics and Pharmacology, pp. 212-227, (1985)

[8]

Kallay F., Janzso G., Koczar I., Thermal rearrangement of 2′-hydroxychal-cone hydrazone and flavanone hydrazone derivatives, Tetrahedron, 21, pp. 3037-3041, (1965)

[9]

Kallay F., Janzso G., Koczar I., The reaction of flavanone with hydrazine, Tetrahedron, 21, pp. 19-24, (1965)

[10]

Marshall W.S., Whitesitt C.A., Goodson T., Roman C., Rinkema L., Fleisch J.H., Structure-accivity relationships (SAR) of the 3-alkyl substituents among a series of hydroxyacetophenone leukotriene antagonists, Agents and Actions, 21, pp. 275-277, (1987)

← 1 2 →